Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
| 4.52 Data as of Apr 17 |  +0.02 / +0.44%Today’s Change | 2.05 Today|||52-Week Range 7.09 | -15.21% Year-to-Date |
Latest MACK News | Press Releases
Today’s Trading
| Previous close | 4.50 |
| Today’s open | 4.50 |
| Day’s range | 4.41 - 4.65 |
| Volume | 725,593 |
| Average volume (3 months) | 1,435,319 |
| Market cap | $504.9M |
| Dividend yield | -- |
Data as of 3:59pm ET, 04/17/2014
Growth & Valuation
| Earnings growth (last year) | -5.32% |
| Earnings growth (this year) | +11.99% |
| Earnings growth (next 5 years) | +5.61% |
| Revenue growth (last year) | -2.32% |
| P/E ratio | NM |
| Price/Sales | 11.04 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INFIInfinity Pharmaceuti... | -0.45 | -4.25% |
| VVUSVIVUS Inc | +0.11 | +2.10% |
| RPTPRaptor Pharmaceutica... | -0.27 | -3.18% |
| ARRYArray Biopharma Inc | -0.05 | -1.30% |
Data as of 3:59pm ET, 04/17/2014
Financials
| Next reporting date | May 13, 2014 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $47.8M |
| Annual profit (last year) | -$130.9M |
| Net profit margin | -273.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Robert J. Mulroy |
Senior Vice President- Operations William M. McClements |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
